Joseph DeSimone
Lua error in package.lua at line 80: module 'strict' not found.
| Joseph DeSimone | |
|---|---|
| File:Joseph DeSimone 2010 11 22 History Live.JPG
DeSimone in 2010
|
|
| Born | May 16, 1964 |
| Citizenship | United States |
| Nationality | United States |
| Institutions | University of North Carolina at Chapel Hill, North Carolina State University |
| Alma mater | Ursinus College, Virginia Polytechnic Institute and State University |
| Doctoral advisor | James E. McGrath |
| Notable awards | Lemelson–MIT Prize (2008) IRI Medal (2014) |
Joseph M. DeSimone (born May 16, 1964) is an American chemist, and the 2008 recipient of the $500,000 Lemelson–MIT Prize.[1]
He is the Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering at North Carolina State University and of Chemistry at UNC. DeSimone is also an adjunct member at Memorial Sloan-Kettering Cancer Center.[2]
DeSimone has published over 300 scientific articles and has over 150 issued patents in his name with over 80 patents pending.
Contents
Education
Joseph DeSimone received his BS in Chemistry in 1986 from Ursinus College in Collegeville, Pennsylvania and his Ph.D. in Chemistry in 1990 from Virginia Tech in Blacksburg, Virginia.[3][4]
Career
DeSimone is a member of all three of the U.S. national academies: the Institute of Medicine (2014),[5] the U.S. National Academy of Sciences (2012),[6] and the U.S. National Academy of Engineering (2005).[7] He is also a member of the American Academy of Arts and Sciences (2005).[8] DeSimone has received over 50 major awards and recognitions. In addition to the Lemelson–MIT Prize, his honors include the 2015 Kabiller Prize in Nanoscience and Nanomedicine;[9] the 2014 IRI Medal; the 2014 American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success;[10] the 2012 Walston Chubb Award for Innovation, presented by Sigma Xi, The Scientific Research Society, to honor and promote creativity in science and engineering;[11] the 2010 AAAS Mentor Award in recognition of his efforts to advance diversity in the chemistry PhD workforce;[12] the 2009 NIH Director's Pioneer Award;[13] the 2009 North Carolina Award, the highest honor the State of North Carolina can bestow to recognize notable achievements of North Carolinians in the fields of Literature, Science, the Fine Arts and Public Service; the 2008 Tar Heel of the Year by the Raleigh News & Observer; the 2007 Collaboration Success Award from the Council for Chemical Research; the 2005 American Chemical Society Award for Creative Invention; the 2002 John Scott Award presented by the Board of Directors of City Trusts, Philadelphia, given to "the most deserving" men and women whose inventions have contributed in some outstanding way to the "comfort, welfare and happiness" of mankind;[14] the 2002 Engineering Excellence Award by DuPont; the 2002 Wallace H. Carothers Award from the Delaware Section of the American Chemical Society; and the 2000 Oliver Max Gardner Award from the University of North Carolina.
| External video | |
|---|---|
 Joseph DeSimone: What if 3D printing was 100x faster?, TED Talks |
Among DeSimone’s notable inventions is an environmentally friendly manufacturing process that relies on supercritical carbon dioxide instead of water and bio-persistent surfactants (detergents) for the creation of fluoropolymers or high performance plastics, such as Teflon. In 2002, DeSimone, along with Dr. Richard Stack, a cardiologist at Duke, co-founded Bioabsorbable Vascular Solutions (BVS) to commercialize a fully bioabsorbable, drug-eluting stent. BVS was acquired by Guidant Corporation in 2003 and these stents are now being evaluated in a series of international clinical trials for the treatment of coronary artery disease.
DeSimone’s research group is heavily focused on learning how to bring the precision, uniformity and mass production techniques associated with the fabrication of nanoscale features found in the microelectronics industry to the nanomedicine field for the fabrication and delivery of vaccines and therapeutics for the treatment and prevention of diseases. Developed in the DeSimone Lab, the PRINT technology (Particle Replication in Non-Wetting Templates) is central to the group's work.
DeSimone also founded Liquidia Technologies in 2004.
DeSimone’s laboratory and the PRINT technology became a foundation for the Carolina Center for Cancer Nanotechnology Excellence funded by the National Cancer Institute.[15]
Currently, DeSimone is on sabbatical leave from the University of North Carolina and is serving as CEO of Silicon Valley company, Carbon3D Inc., where he co-invented a new 3D printing technology called Continuous Liquid Interface Production (CLIP).[16]
References
- ↑ Winners' Circle: Joseph M. DeSimone
- ↑ Memorial Sloan-Kettering Cancer Center
- ↑ DeSimone Research Group: People: DeSimone
- ↑ UNC Faculty: DeSimone
- ↑ Institute of Medicine Elects 70 New Members, 10 Foreign Associates (October 20, 2014)
- ↑ National Academy of Sciences Members and Foreign Associates Elected (May 1, 2012)
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Joseph DeSimone Receives $250,000 Kabiller Prize in Nanoscience and Nanomedicine
- ↑ Kathryn C. Hach Award For Entrepreneurial Success (3 March 2014)
- ↑ Joseph DeSimone, 2012 Walston Chubb Award for Innovation
- ↑ 2010 AAAS Mentor Award Goes to Joseph M. DeSimone of the University of North Carolina at Chapel Hill and North Carolina State University (16 February 2011)
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ UNC-Chapel Hill researchers collaborate to develop revolutionary 3D printing technology
